Where does GT Medical Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GT Medical Technologies, Inc. ranks #22,676 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GT Medical Technologies, Inc. hold?

GT Medical Technologies, Inc. holds 12 US utility patents granted between 2018 and 2024, spanning 4 technology areas.

What is GT Medical Technologies, Inc.'s Innovation Score?

GT Medical Technologies, Inc. has an Innovation Score of 31.9 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GT Medical Technologies, Inc. focus on?

GT Medical Technologies, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 12 patents, ranking #298 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is GT Medical Technologies, Inc.'s patent grant rate increasing or decreasing?

GT Medical Technologies, Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for GT Medical Technologies, Inc.'s patents?

GT Medical Technologies, Inc.'s patents average 15.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GT Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

GT Medical Technologies, Inc.

USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, GT ranks #22,676 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.

#22,676
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.9/100): 15.5
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22676 · US Corporation #22,676 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,676/49,997
PHOTO-FINISH Game Changers
CPC-NARROW A61N · 4 areas
INNOV-THIN 31.9/100
CLAIMS-RICH 15.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Game Changers, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How GT’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (28%) Velocity 6.7 pts (21%) Breadth 7.1 pts (22%) Claim depth 9.3 pts (29%)

Qualcomm Incorporated · highest

85
GT Medical · this assignee

32
3D Lighting… · lowest

7

What this shows GT's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for GT?

Each dot is one of GT’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). GT’s own 15.5 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

GT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where GT's grants concentrate

GT Medical Technologies, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2020. By volume, GT sits between Grayl Inc. and Gate CFV Solutions, Inc..

GT's three-year grant acceleration

GT Medical Technologies, Inc. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Grayl

12
Greenthread

12
Grivel S R L

12
GS Cleantech

12
Guangzhou Lanshid…

12
Game Changers

12
Garantir

12
Gate CFV Solutions

12
GT Medical ◀

12

What this shows GT holds 12 patents at rank #22,646, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GT

By rank, the assignees closest to #22,646 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in GT's primary technology class.

GT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

GT Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	16.7%
2019	2	16.7%
2020	1	8.3%
2021	2	16.7%
2022	2	16.7%
2023	2	16.7%
2024	1	8.3%

Which technologies does GT Medical Technologies, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GT Medical Technologies, Inc.'s patent record in context - here's where to go next.

GT Medical Technologies, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #22,676 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GT Medical Technologies, Inc. against Grayl Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.